Skip to main content
. 2020 Jun 25;13:6073–6083. doi: 10.2147/OTT.S254612

Figure 2.

Figure 2

miR-512-3p promotes HCC cell proliferation and motility. (A) In MTT assays miR-512-3p mimics increased Hep3B cell viability. *p < 0.05, analysis of variance, n = 3. (B) In EdU assays miR-512-3p mimics enhanced Hep3B cell proliferation. *p < 0.05, Student’s t-test; n = 3. (C) In MTT assays miR-512-3p inhibitors reduced HCCLM3 cell viability. *p < 0.05, analysis of variance, n = 3. (D) In EdU assays miR-1251-5p inhibitors suppressed MHCC97-H cell proliferation. *p < 0.05, Student’s t-test; n = 3. (E) In transwell migration and invasion assays miR-512-3p mimics enhanced the motility of Hep3B cells compared to control cells. *p < 0.05, Student’s t-test, n = 3. (F) In transwell migration and invasion assays miR-512-3p inhibitors impaired the motility of HCCLM3 cells compared to control cells. *p < 0.05, Student’s t-test; n = 3.